Emergency Plan for AIDS Relief (PEPFAR)

See the following -

New amfAR Report Warns of Trade Agreement’s Potentially Damaging Effects on Global Public Health

Press Release | amfAR | May 8, 2015

The proposed Trans-Pacific Partnership (TPP), a free trade agreement currently being negotiated among 12 Pacific Rim countries, threatens the future availability of affordable generic medicines and could undermine the global HIV response in developing countries, according to a new report released today by amfAR, The Foundation for AIDS Research. By expanding intellectual property (IP) protections for existing pharmaceutical products beyond what is required by current international standards, the report warns, the TPP could greatly delay the entrance of generic medicines into the marketplace and keep drug prices high for those who can least afford them.